MCAM and lung cancer: It was demonstrated that lung cancer brain metastases are more resistant to pemetrexed compared with in situ lung cancer cells (Xu et al., 2020), Consistently, CD146 showed high expression in PC9BrM3 cells with PEM resistance as shown above.